{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Bisantrene_Hydrochloride",
  "nciThesaurus": {
    "casRegistry": "71439-68-4",
    "chebiId": "",
    "chemicalFormula": "C22H22N8.2HCl",
    "definition": "The hydrochloride salt of an anthracenyl bishydrazone with antineoplastic activity. Bisantrene intercalates with and disrupts the helical structure of DNA, resulting in DNA single-strand breaks, DNA-protein crosslinking, and inhibition of DNA replication. This agent is similar to doxorubicin in activity, but unlike doxorubicin, does not exhibit cardiotoxicity.",
    "fdaUniiCode": "74GNV897RO",
    "identifier": "C77218",
    "preferredName": "Bisantrene Hydrochloride",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C253"
    ],
    "synonyms": [
      "9,10,Anthracenedicarboxaldehyde Dihydrochloride",
      "9,10-Anthracenedicarboxakdehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] Dihydrochloride",
      "9,10-Anthracenedicarboxaldehyde Bis(2-imidazolin-2-yl)hydrazone Dihydrochloride",
      "BISANTRENE HYDROCHLORIDE",
      "Bisantrene Dihydrochloride",
      "Bisantrene Hydrochloride",
      "CL 216942",
      "CL-216942",
      "Orange Crush",
      "Zantrene"
    ]
  }
}